MyCartis Overview

  • Founded
  • 2014
  • Status
  • Private
  • Employees
  • 51
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 8

MyCartis General Information


Provider of a biomarker analysis platform. The company develops a multiplex analysis platform that analyzes protein and nucleic-acid based biomarkers.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Devices and Supplies
Primary Office
  • EPFL Innovation Park
  • Bâtiment G
  • CH-1015 Lausanne
  • Switzerland
+41 021 000 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

MyCartis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Accelerator/Incubator 000.00 Completed Startup
1. Early Stage VC 04-Sep-2014 000.00 000.00 Completed Startup
To view MyCartis’s complete valuation and funding history, request access »

MyCartis Patents

MyCartis Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20200290038-A1 Prefilled cartridge Pending 12-Oct-2016 000000000000
EP-3512633-A1 Prefilled cartridge Withdrawn 12-Oct-2016 000000000000
JP-2018537661-A Use of cd146 as a marker of vessel wall tension Pending 06-Nov-2015 00000000000
US-20180321257-A1 Use of cd146 as a marker of the vascular wall tension Abandoned 06-Nov-2015 00000000000
AU-2016347740-A1 Use of cd146 as a marker of the vascular wall tension Abandoned 06-Nov-2015 G01N33/6893

MyCartis Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

MyCartis Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Aescap Life Sciences Mutual Fund Minority 000 0000 000000 0
Biover II Venture Capital Minority 000 0000 000000 0
PMV Asset Manager Minority 000 0000 000000 0
Rudi Marien Angel (individual) Minority 000 0000 000000 0
Valiance PE/Buyout Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »